Literature DB >> 32948976

Serum Magnesium and Fractional Exhaled Nitric Oxide in Relation to the Severity in Asthma-Chronic Obstructive Pulmonary Disease Overlap.

Mingzhi Ye1, Qianhong Li1, Ling Xiao1, Zhongsheng Zheng2.   

Abstract

Serum concentrations of magnesium and manganese may be associated with increased chronic obstructive pulmonary disease exacerbation risk. However, associations with other aspects of asthma-chronic obstructive pulmonary disease overlap, pulmonary function test results and health status, have been studied less extensively. The aim of this study was to investigate the associations between serum concentrations of trace elements and T lymphocyte subsets, FeNO, and COPD-related questionnaire scores in individuals with ACO and the potential impact of these parameters on lung function. All the patients met the diagnostic criteria of ACO and were divided into two groups (group A, mild-moderate; group B, severe-very severe) by their specific characteristics. Pulmonary function testing and serum Mg and serum Mn and FeNO were measured. Four hundred sixty-five patients were screened, and 42 were included. Group A had significantly higher Mg and Fe concentrations than group B. No significant differences were seen in the serum concentration of any other trace element between the two groups. Serum Mg and Mn were correlated with FEV1% predicted (p < 0.01). Group A had a significantly higher FeNO concentration than group B (p = 0.005). The scores on CAT (p = 0.011) and mMRC (p = 0.008) in group A were lower than in group B. The low-FeNO group had a significantly lower concentration of serum Mg than the high-FeNO group (p = 0.03). Pulmonary function declined faster (p < 0.05) in the low-FeNO group than the high-FeNO group. Serum Mg concentration may indicate protective effects against lung function loss in ACO. This implies that FeNO might be a biomarker for identifying individuals with ACO who might benefit from inhaled corticosteroid therapy. Serum Mg and FeNO were associated with ACO severity. However, their role in guiding personalised treatment of individuals with ACO needs to be further investigated.

Entities:  

Keywords:  ACO; FENO; FEV1; Magnesium; Manganese

Mesh:

Substances:

Year:  2020        PMID: 32948976     DOI: 10.1007/s12011-020-02314-5

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  6 in total

1.  Intravenous magnesium sulphate as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease: a single centre, randomised, double-blinded, parallel group, placebo-controlled trial: a pilot study.

Authors:  Saptarshi Mukerji; Berinder Shahpuri; Bevan Clayton-Smith; Nicola Smith; Patrick Armstrong; Moira Hardy; George Marchant; Emma Marsh
Journal:  N Z Med J       Date:  2015-11-20

Review 2.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

Authors:  Dave Singh; Alvar Agusti; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Gerard J Criner; Peter Frith; David M G Halpin; Meilan Han; M Victorina López Varela; Fernando Martinez; Maria Montes de Oca; Alberto Papi; Ian D Pavord; Nicolas Roche; Donald D Sin; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Claus Vogelmeier
Journal:  Eur Respir J       Date:  2019-05-18       Impact factor: 16.671

3.  Normal reference ranges for and variability in the levels of blood manganese and selenium by gender, age, and race/ethnicity for general U.S. population.

Authors:  Ram B Jain; Y Sammy Choi
Journal:  J Trace Elem Med Biol       Date:  2014-12-22       Impact factor: 3.849

4.  Effects of smoking on trace metal levels in saliva.

Authors:  Y-J Kim; Y-K Kim; H-S Kho
Journal:  Oral Dis       Date:  2010-11       Impact factor: 3.511

5.  Evaluation of malnutrition detected with the Nutritional Risk Screening 2002 (NRS-2002) and the quality of life in hospitalized patients with chronic obstructive pulmonary disease.

Authors:  M Arslan; M Soylu; G Kaner; N İnanç; E Başmısırlı
Journal:  Hippokratia       Date:  2016 Apr-Jun       Impact factor: 0.471

Review 6.  Effects of manganese on thyroid hormone homeostasis: potential links.

Authors:  O P Soldin; M Aschner
Journal:  Neurotoxicology       Date:  2007-05-13       Impact factor: 4.294

  6 in total
  7 in total

Review 1.  Unraveling the Pathogenesis of Asthma and Chronic Obstructive Pulmonary Disease Overlap: Focusing on Epigenetic Mechanisms.

Authors:  Yung-Che Chen; Yu-Ping Chang; Kuo-Tung Huang; Po-Yuan Hsu; Chang-Chun Hsiao; Meng-Chih Lin
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

2.  The Combined Value of Type2 Inflammatory Markers in Chronic Obstructive Pulmonary Disease.

Authors:  Yunhuan Liu; Guanhua Ma; Yan Mou; Xuanqi Liu; Wenjia Qiu; Yang Zheng; Huili Zhu; Haiyan Ge
Journal:  J Clin Med       Date:  2022-05-16       Impact factor: 4.964

3.  The Relation Between Trace Element Status (Zinc, Copper, Magnesium) and Clinical Outcomes in COVID-19 Infection During Pregnancy.

Authors:  Ali Taner Anuk; Naci Polat; Sevginur Akdas; Seyit Ahmet Erol; Atakan Tanacan; Derya Biriken; Huseyin Levent Keskin; Ozlem Moraloglu Tekin; Nuray Yazihan; Dilek Sahin
Journal:  Biol Trace Elem Res       Date:  2020-11-24       Impact factor: 4.081

4.  Health-Related Quality of Life and Nutritional Status Are Related to Dietary Magnesium Intake in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.

Authors:  Afsane Ahmadi; Mohammad Hassan Eftekhari; Zohreh Mazloom; Masoom Masoompour; Mohammad Fararooei; Morteza Zare; Najmeh Hejazi
Journal:  Clin Nutr Res       Date:  2022-01-31

5.  The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.

Authors:  Meng Li; Tian Yang; Ruiqing He; Anqi Li; Wenhui Dang; Xinyu Liu; Mingwei Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-20

6.  Comparative Analysis of Serum Zinc, Copper and Magnesium Level and Their Relations in Association with Severity and Mortality in SARS-CoV-2 Patients.

Authors:  Kiran Kumar Pvsn; Sojit Tomo; Purvi Purohit; Shrimanjunath Sankanagoudar; Jayakaran Charan; Abhishek Purohit; Vijaylakshami Nag; Pradeep Bhatia; Kuldeep Singh; Naveen Dutt; Mahendra Kumar Garg; Praveen Sharma; Sanjeev Misra; Dharamveer Yadav
Journal:  Biol Trace Elem Res       Date:  2022-01-22       Impact factor: 4.081

7.  Clinical trial on the effects of oral magnesium supplementation in stable-phase COPD patients.

Authors:  Bruno Micael Zanforlini; Chiara Ceolin; Caterina Trevisan; Agnese Alessi; Daniele Michele Seccia; Marianna Noale; Stefania Maggi; Gabriella Guarnieri; Andrea Vianello; Giuseppe Sergi
Journal:  Aging Clin Exp Res       Date:  2021-07-14       Impact factor: 3.636

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.